nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allosteric modulators of ligand binding to muscarinic acetylcholine receptors
|
Holzgrabe, Ulrike |
|
1998 |
3 |
5 |
p. 214-222 9 p. |
artikel |
2 |
Chiroscience/BMS MMP inhibitor progress
|
Bradley, David |
|
1998 |
3 |
5 |
p. 196- 1 p. |
artikel |
3 |
Combinatorial Chemistry
|
Terrett, Nick |
|
1998 |
3 |
5 |
p. 242- 1 p. |
artikel |
4 |
ERT cancer suspect?
|
Bradley, David |
|
1998 |
3 |
5 |
p. 200- 1 p. |
artikel |
5 |
Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development
|
Verpoorte, Rob |
|
1998 |
3 |
5 |
p. 232-238 7 p. |
artikel |
6 |
Factor Xa inhibitors by classical and combinatorial chemistry
|
Al-Obeidi, Fahad |
|
1998 |
3 |
5 |
p. 223-231 9 p. |
artikel |
7 |
IL-6 as a drug discovery target
|
Stein, Bernd |
|
1998 |
3 |
5 |
p. 202-213 12 p. |
artikel |
8 |
InfoTech Pharma '98: managing the knowledge
|
Thorne, Matthew |
|
1998 |
3 |
5 |
p. 197-199 3 p. |
artikel |
9 |
Monitor: molecules and profiles
|
Lloyd, A |
|
1998 |
3 |
5 |
p. 239-240 2 p. |
artikel |
10 |
Neuronal nicotinic ACh receptor modulators
|
Holladay, Mark W |
|
1998 |
3 |
5 |
p. 240-241 2 p. |
artikel |
11 |
Proteomics: key technology in drug discovery
|
Celis, Julio E |
|
1998 |
3 |
5 |
p. 193-195 3 p. |
artikel |